Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Hyundai Pharmaceutical Co., Ltd. (004310)
Market Closed
15 Jun, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
7,440.
00
+1,710
+29.8429%
₩
155.25B
Market Cap
-
P/E Ratio
120%
Div Yield
959,358
Volume
0
Eps
₩
5,730
Previous Close
Watching
Watch
Add Transaction
Day Range
6,760
7,440
Year Range
3,380
15,960
Want to track
004310
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Hyundai Pharmaceutical Co., Ltd. (004310) Statistics
Valuation metrics
Market Cap
155.25B
Enterprise value
181.21B
Trailing P/E (ttm)
35.85
Forward P/E
-
PEG ratio
0.04
Price/Sales (ttm)
0.77
Price/Book (mrq)
1.11
Enterprise Value/Revenue
0.93
Enterprise Value/EBITDA
15.89
Overview
Shares outstanding
26.14M
Float
16.86M
Shares short
-
% Held by insiders
0.32%
% Held by institutions
0%
Average volume (10 days)
247.96K
Average volume (90 days)
405.29K
Price summary
52-Week low
3,380
52-Week high
15,960
Beta
0.84
50-Day moving average
7,307.81
200-Day moving average
8,720.9
Dividends and splits
Forward annual dividend rate
120
Forward annual dividend yield
0.0164%
Trailing annual dividend rate
30
Trailing annual dividend yield
0.0052%
5-Year annual dividend yield
0.77%
Payout ratio
0.19
Dividend Date
3 Mar 2026
Ex-Dividend Date
3 Mar 2026
Last split factor
513:500
Last split Date
20 Oct 2017
Financials
Fiscal year
Fiscal year ends
30 Nov 2013
Most recent quarter (mrq)
28 Feb 2026
Profitability
Profit margin
0.02%
Operating margin
0.03%
Operational effectiveness
Return on assets
0.02%
Return on equity
0.04%
Income Statement
Revenue (ttm)
108.14B
Revenue per share (ttm)
7,446.52
Quarterly revenue growth (yoy)
0.05%
Gross profit (ttm)
40.49B
EBITDA
8.57B
Net income to common (ttm)
1.41B
Diluted EPS (ttm)
159.83
Quarterly earnings growth (yoy)
0.08%
Balance Sheet
Total cash (mrq)
14.63B
Total cash per share (mrq)
712.27
Total debt (mrq)
20.75B
Total Debt/Equity (mrq)
0.37
Current ratio (mrq)
1.28%
Book value per share (mrq)
5,143.92
Cash Flow
Cash flow statement
7.95B
Levered free cash flow (LFCF)
6.29B